Cargando…

Second- and Third-Tier Therapies for Severe Traumatic Brain Injury

Intracranial hypertension is a common finding in patients with severe traumatic brain injury. These patients need treatment in the intensive care unit, where intracranial pressure monitoring and, whenever possible, multimodal neuromonitoring can be applied. A three-tier approach is suggested in curr...

Descripción completa

Detalles Bibliográficos
Autores principales: Vrettou, Charikleia S., Mentzelopoulos, Spyros D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410180/
https://www.ncbi.nlm.nih.gov/pubmed/36013029
http://dx.doi.org/10.3390/jcm11164790
_version_ 1784775031876747264
author Vrettou, Charikleia S.
Mentzelopoulos, Spyros D.
author_facet Vrettou, Charikleia S.
Mentzelopoulos, Spyros D.
author_sort Vrettou, Charikleia S.
collection PubMed
description Intracranial hypertension is a common finding in patients with severe traumatic brain injury. These patients need treatment in the intensive care unit, where intracranial pressure monitoring and, whenever possible, multimodal neuromonitoring can be applied. A three-tier approach is suggested in current recommendations, in which higher-tier therapies have more significant side effects. In this review, we explain the rationale for this approach, and analyze the benefits and risks of each therapeutic modality. Finally, we discuss, based on the most recent recommendations, how this approach can be adapted in low- and middle-income countries, where available resources are limited.
format Online
Article
Text
id pubmed-9410180
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94101802022-08-26 Second- and Third-Tier Therapies for Severe Traumatic Brain Injury Vrettou, Charikleia S. Mentzelopoulos, Spyros D. J Clin Med Review Intracranial hypertension is a common finding in patients with severe traumatic brain injury. These patients need treatment in the intensive care unit, where intracranial pressure monitoring and, whenever possible, multimodal neuromonitoring can be applied. A three-tier approach is suggested in current recommendations, in which higher-tier therapies have more significant side effects. In this review, we explain the rationale for this approach, and analyze the benefits and risks of each therapeutic modality. Finally, we discuss, based on the most recent recommendations, how this approach can be adapted in low- and middle-income countries, where available resources are limited. MDPI 2022-08-16 /pmc/articles/PMC9410180/ /pubmed/36013029 http://dx.doi.org/10.3390/jcm11164790 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Vrettou, Charikleia S.
Mentzelopoulos, Spyros D.
Second- and Third-Tier Therapies for Severe Traumatic Brain Injury
title Second- and Third-Tier Therapies for Severe Traumatic Brain Injury
title_full Second- and Third-Tier Therapies for Severe Traumatic Brain Injury
title_fullStr Second- and Third-Tier Therapies for Severe Traumatic Brain Injury
title_full_unstemmed Second- and Third-Tier Therapies for Severe Traumatic Brain Injury
title_short Second- and Third-Tier Therapies for Severe Traumatic Brain Injury
title_sort second- and third-tier therapies for severe traumatic brain injury
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410180/
https://www.ncbi.nlm.nih.gov/pubmed/36013029
http://dx.doi.org/10.3390/jcm11164790
work_keys_str_mv AT vrettoucharikleias secondandthirdtiertherapiesforseveretraumaticbraininjury
AT mentzelopoulosspyrosd secondandthirdtiertherapiesforseveretraumaticbraininjury